Agnostic Metagenomic Next-Generation Sequencing (mNGS) for Clinical Diagnostics
DEPT OF DEFENSE
About this opportunity
DISCLAIMER This is an information request only. This request is issued solely for information and planning purposes � it does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. Solicitations are not available currently. This notice does not constitute a commitment by the United States Government to contract for any supply or service whatsoever. Purpose: The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) invites you to collaborate on a critical mission: to develop a field-forward, threat-agnostic metagenomic next-generation sequencing (mNGS) capability for rapid identification of traditional, novel, emerging, and engineered infectious disease agents. This initiative seeks to address a critical gap in ...